Prognostic value of microsatellite instability (MSI)/deficient mismatch repair (MMR) and BRAFV600E mutation in recurring stage III colon cancer: insights from an ACCENT pooled analysis of seven adjuvant chemotherapy trials

Anuratha Sakthianandeswaren, Dmitri Mouradov, Oliver M. Sieber